Alex D'Amico's Net Worth
$748 Thousand
Who is Alex D'Amico?
Alex D'Amico does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trulieve Cannabis Corp., Synvista Therapeutics, Inc., and Cytosorbents Corp.
SEC CIK
Alex D'Amico's CIK is 0001419928
Past Insider Trading and Trends
2021 was Alex D'Amico's most active year for acquiring shares with 5 total transactions. Alex D'Amico's most active month to acquire stocks was the month of August. 2022 was Alex D'Amico's most active year for disposing of shares, totalling 1 transactions. Alex D'Amico's most active month to dispose stocks was the month of November. 2007 saw Alex D'Amico paying a total of $26,700.00 for 10,000 shares, this is the most they've acquired in one year. In 2022 Alex D'Amico cashed out on 2,718 shares for a total of $21,037.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trulieve Cannabis Corp. (TCNNF) Snapshot price: $9.55
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.18% | -2.72K |
$7.74 | -$21,037.32 | 82.87K |
Dec 29
| |||
Form 4
| +1.78% | 1.5K |
$14.39 | $21,585.00 | 85.59K |
May 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 20.14K |
—
|
—
| 20.14K |
Feb 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| +570.57% | 16.09K |
—
|
—
| 18.91K |
Sep 29
| |||
Form 4
| +30.56% | 660 |
$27.00 | $17,820.00 | 2.82K |
Aug 17
| |||
Form 4
| +44.00% | 660 |
$38.00 | $25,077.36 | 2.16K |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synvista Therapeutics, Inc. No price found
principal accounting officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cytosorbents Corp (CTSO) Snapshot price: $0.9903
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||